Preliminary Results of a Phase 1 Dose-Escalation Trial for Early-Stage Breast Cancer Using 5-Fraction Stereotactic Body Radiation Therapy for Partial-Breast Irradiation

International Journal of Radiation Oncology Biology Physics

Volumn 98, Issue 1, 2017, Pages 196-205.e2

  Rahimi, Asal ^a   Thomas, Kimberly ^a   Spangler, Ann ^a   Rao, Roshni ^b   Leitch, Marilyn ^b   Wooldridge, Rachel ^b   Rivers, Aeisha ^b   Seiler, Stephen ^b   Albuquerque, Kevin ^a   Stevenson, Stella ^a   Goudreau, Sally ^b   Garwood, Dan ^a   Haley, Barbara ^b   Euhus, David ^c   Heinzerling, John ^d   Ding, Chuxiong ^a   Gao, Ang ^a   Ahn, Chul ^a   Timmerman, Robert ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LEVINE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; IRRADIATION; PATIENT TREATMENT; RADIATION; SURVEYS; TOXICITY;

DISTANT METASTASIS; DOSE LIMITING TOXICITY; DUCTAL CARCINOMA IN SITU; EARLY-STAGE BREAST CANCER; MAXIMUM TOLERATED DOSE; METHODS AND MATERIALS; PARTIAL BREAST IRRADIATION; STEREOTACTIC BODY RADIATION THERAPY;

RADIOTHERAPY;

ACUTE TOXICITY; ADULT; ARTICLE; BODY MASS; BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; DISTANT METASTASIS; EARLY CANCER; ESTHETICS; FAT NECROSIS; FATIGUE; FEMALE; FIBROSIS; FOLLOW UP; HUMAN; HYPERPIGMENTATION; INTRADUCTAL CARCINOMA; LUMPECTOMY; MAJOR CLINICAL STUDY; MASTALGIA; MASTITIS; MIDDLE AGED; PARESTHESIA; PARTIAL MASTECTOMY; PATIENT COMPLIANCE; PHYSICIAN; PRIORITY JOURNAL; QUESTIONNAIRE; RADIATION DERMATITIS; RADIATION DOSE; RADIATION DOSE ESCALATION; RADIATION INJURY; RIB FRACTURE; ROBOTICS; STEREOTACTIC BODY RADIATION THERAPY; TELANGIECTASIA; THORAX PAIN; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR VOLUME; ADJUVANT RADIOTHERAPY; ADVERSE EFFECTS; AGED; BREAST CARCINOMA IN SITU; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CLINICAL TRIAL; DIAGNOSTIC IMAGING; FEASIBILITY STUDY; FIDUCIAL MARKER; PATHOLOGY; PHASE 1 CLINICAL TRIAL; PROCEDURES; PROSPECTIVE STUDY; RADIATION DOSE FRACTIONATION; RADIATION TOLERANCE; RADIOSURGERY;

AGED; BREAST CARCINOMA IN SITU; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DOSE FRACTIONATION; FEASIBILITY STUDIES; FEMALE; FIDUCIAL MARKERS; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; PROSPECTIVE STUDIES; RADIATION TOLERANCE; RADIOSURGERY; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 85017324940     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2017.01.020     Document Type: Article

References (38)

1. 1 Farrow, D., Hunt, W.C., Samet, J.M., Geographic variation in the treatment of localized breast cancer. N Engl J Med 326 (1992), 1097–1101.
2. 2 American Cancer Society. Breast Cancer Facts & Figures 2015-2016. 2015, American Cancer Society, Atlanta, GA.
3. 3 Bartelink, H., Horiot, J., Poortmans, P., et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 345 (2001), 1378–1387.
4. 4 Rosen, P., Fracchia, A., Urban, J., et al. “Residual” mammary carcinoma following simulated partial mastectomy. Cancer 35 (1975), 739–747.
5. 5 Keisch, M., Vicini, F., Kuske, R., et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 55 (2003), 289–293.
6. 6 Schroen, A., Brenin, D., Kelly, M., et al. Impact of patient distance to radiation therapy on mastectomy use in early-stage breast cancer patients. J Clin Oncol 23 (2005), 7074–7080.
7. 7 Timmerman, R., Paulus, R., Galvin, J., et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 303 (2010), 1070–1076.
8. 8 Formenti, S., Rosenstein, B., Skinner, K., et al. T1 stage breast cancer: Adjuvant hypofractionated conformal radiation therapy to tumor bed in selected postmenopausal breast cancer patients–pilot feasibility study. Radiology 222 (2002), 171–178.
9. 9 Rusthoven, K., Kavanagh, B., Cardenes, H., et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 27 (2009), 1572–1578.
10. 10 Bondiau, P., Bahadoran, P., Lallement, M., et al. Robotic stereotactic radioablation concomitant with neo-adjuvant chemotherapy for breast tumors. Int J Radiat Oncol Biol Phys 75 (2009), 1041–1047.
11. 11 Qi, X., White, J., Li, X., Is α/β for breast cancer really low?. Radiother Oncol 100 (2011), 282–288.
12. 12 Seiler, S., Rahimi, A., Choudhery, S., et al. Ultrasound-guided placement of gold fiducial markers for stereotactic partial-breast irradiation. Am J Roentgenol 207 (2016), 685–688.
13. 13 Kilby, W., Dooley, J.R., Kuduvalli, G., et al. The CyberKnife robotic radiosurgery system in 2010. Technol Cancer Res Treat 9 (2010), 433–452.
14. 14 Simon, R., Designs and analysis of clinical trials. DeVita, V.T., Lawrence, T.S., Rosenberg, S.A., (eds.) Cancer: Principles and Practice of Oncology, 2011, Lippincott, Williams, and Wilkins, Philadelphia, 705.
15. 15 Barton, M., Keane, T., Gadalla, T., et al. The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer. Radiother Oncol 23 (1992), 137–143.
16. 16 Park, C., Papiez, L., Zhang, S., et al. Universal survival curve and single fraction equivalent dose: Useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys 70 (2008), 847–852.
17. 17 Weichselbaum, R.R., Nove, J., Little, J.B., X-ray sensitivity of human tumor cells in vitro. Int J Radiat Oncol Biol Phys 6 (1980), 437–440.
18. 18 Liebmann, J., Cook, J.A., Fisher, J., et al. Changes in radiation survival curve parameters in human tumor and rodent cells exposed to paclitaxel (Taxol). Int J Radiat Oncol Biol Phys 29 (1994), 559–564.
19. 19 Phillips, T.M., McBride, W.H., Pajonk, F., The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 98 (2006), 1777–1785.
20. 20 Fisher, B., Anderson, S., Bryant, J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 (2002), 1233–1241.
21. 21 Clark, R., Whelan, T., Levine, M., et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: An update. Ontario Clinical Oncology Group. J Natl Cancer Inst 88 (1996), 1659–1664.
22. 22 Veronesi, U., Marubini, E., Mariani, L., et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial. Ann Oncol 12 (2001), 997–1003.
23. 23 Fentiman, I., Poole, C., Tong, D., et al. Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer 32A (1996), 608–611.
24. 24 Fentiman, I., Poole, C., Tong, D., et al. Iridium implant treatment without external radiotherapy for operable breast cancer: A pilot study. Eur J Cancer 27 (1991), 447–450.
25. 25 Vicini, F., Kini, V., Chen, P., et al. Irradiation of the tumor bed alone after lumpectomy in selected patients with early-stage breast cancer treated with breast conserving therapy. J Surg Oncol 70 (1999), 33–40.
26. 26 Baglan, K., Sharpe, M., Jaffray, D., et al. Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys 55 (2003), 302–311.
27. 27 Ribeiro, G., Dunn, G., Swindell, R., et al. Conservation of the breast using two different radiotherapy techniques: Interim report of a clinical trial. Clin Oncol (R Coll Radiol) 2 (1990), 27–34.
28. 28 Ribeiro, G., Magee, B., Swindell, R., et al. The Christie Hospital breast conservation trial: An update at 8 years from inception. Clin Oncol (R Coll Radiol) 5 (1993), 278–283.
29. 29 Veronesi, U., Orecchia, R., Luini, A., et al. A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer 37 (2001), 2178–2183.
30. 30 Hepel, J., Tokita, M., MacAusland, S., et al. Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 75 (2009), 1290–1296.
31. 31 Jagsi, R., Ben-David, M., Moran, J., et al. Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys 76 (2009), 71–78.
32. 32 Olivotto, I., Whelan, T., Parpia, S., et al. Interim cosmetic and toxicity results from RAPID: A randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy. J Clin Oncol 31 (2013), 4038–4045.
33. 33 Heinzerling, J., Ding, C., Ramirez, E., et al. Comparative dose-volume analysis for CyberKnife and 3D conformal partial breast irradiation treatment of early stage breast cancer. Int J Radiat Oncol Biol Phys 78 (2010), S825–S826.
34. 34 Vermeulen, S., Haas, J., CyberKnife stereotactic body radiotherapy and CyberKnife accelerated partial breast irradiation for the treatment of early breast cancer. Transl Cancer Res 3 (2014), 295–302.
35. 35 Horton, J.K., Blitzbau, R.C., Yoo, S., et al. Preoperative single-fraction partial breast radiation therapy: A novel phase 1, dose-escalation protocol with radiation response biomarkers. Int J Radiat Oncol Biol Phys 92 (2015), 846–855.
36. 36 Palta, M., Yoo, S., Adamson, J.D., et al. Preoperative single fraction partial breast radiotherapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys 82 (2014), 37–42.
37. 37 Yu, C.X., Shao, X., Zhang, J., et al. GammaPod-a new device dedicated for stereotactic radiotherapy of breast cancer. Med Phys, 40, 2013, 051703.
38. 38 Julian T, Constantino J, Vicini F, et al. Early toxicity results with 3D conformal external beam therapy (CEBT) from the NSABP B-39/RTOG 0413 accelerated partial breast irradiation (APBI) trial. Presented at the American Society for Radiation Oncology 53rd Annual Meeting, October 2-6, 2011, Miami Beach, FL.